A recent analysis of mouse and human single and bulk RNA-seq data revealed that PPARγ controls the expression of a set of antifibrotic miRNAs, including miR-30, miR-29c, and miR-338, that are important for the maintenance of low profibrotic protein levels during HCC-related liver fibrosis [71]. This evidence concerns the gene PPARG and hepatocellular carcinoma.